Recently, KIF14 has been reported as a prognostic biomarker and oncogene in certain carcinomas, including breast cancer, colorectal cancer, gastric cancer, HCC, lung cancer, ovarian cancer, retinoblastoma, and glioblastoma [32, 34–36, 38, 57]. This evidence concerns the gene KIF14 and breast carcinoma.